The role of autolysis loop in determining the specificity of coagulation proteases

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 8, 2007, Pages 1055-1064

  Yang, L ^a   Manithody, C ^a   Rezaie, A R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activated protein C; Antithrombin; Factor Va; Factor Xa; Serpins

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5A; MUTANT PROTEIN; PENTASACCHARIDE; PROTEINASE; SERINE PROTEINASE INHIBITOR; TRYPSIN;

ARTICLE; BLOOD CLOTTING; ENZYME ANALYSIS; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

EID: 34547733426     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006005000137     Document Type: Article

References (29)

1. Damus PS, Hicks M, Rosenberg RD. Anticoagulant action of heparin. Nature 1973; 246: 355-357.
2. Carrell RW, Stein PE, Fermi G, Wardell MR. Biological implications of a 3 A structure of dimeric antithrombin. Structure 1994; 2: 257-270.
3. Olson ST, Björk I. Regulation of thrombin by antithrombin and heparin co-factor II. In: Berliner LJ (Editor), Thrombin: structure and function. New York: Plenum Press; 1992. p 159-217.
4. Bock SC, Wion KL, Vehar GA, Lawn RM. Cloning and expression of the cDNA for human antithrombin III. Nucleic Acids Res 1982; 10: 8113-8125.
5. Gettins PG. Serpin structure, mechanism, and function. Chem Rev 2002; 102: 4751-4804.
6. Jin L, Abrahams JP, Skinner R, Petitou M, Pike RN, Carrell RW. The anticoagulant activation of antithrombin by heparin. Proc Natl. Acad Sci U S A 1997; 94: 14683-14688.
7. Weitz JI, Hirsh J, Samama MM. New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 265S-286S.
8. Olson ST, Swanson R, Raub-Segall E, Bedsted T, Sadri M, Petitou M, et al. Accellerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. Thromb Haemost 2004; 92: 929-939.
9. Olson ST, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 1992; 267: 12528-12538.
10. Hunlington JA, McCoy A, Belzar KJ, Pei XY, Gettins PG, Carrell RW. The conformational activation of antithrombin. A 2.85-A structure of a fluorescein derivative reveals an electrostatic link between the hinge and heparin binding regions. J Biol Chem 2000; 275: 15377-15383.
11. Rezaie AR. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of haparin binding to factor Xa. J Biol Chem 1998; 273: 16824-16827.
12. Rezaie AR, Olson ST. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promobfig the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies. Biochemistry 2000; 39: 12083-12090.
13. Wiebe EM, Stafford AR, Fredenburgh JC, Weitz JI. Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide. J Biol Chem 2003; 278: 35767-35774.
14. Lane DA, Denton J, Flynn AM, Thunberg L, Lindahl U. Anticoagulant activities of haparin oligosaccharides and their neutralization by platelet factor 4. Biochem J 1984; 218: 725-732.
15. Danielsson A, Raub E, Lindahl U, Bjork I. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem 1986; 261: 15467-15473.
16. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 1989; 8: 3467-3475.
17. Yang L, Manithody C, Rezaie AR. Heparin-activated antithrombin interacts with the autolysis loop of target coaglation proteases. Blood 2004; 104: 1753-1759.
18. Manithody C, Yang L, Rezaie AR. Role of basic residues of the autolysis loop in the catalytic function of factor Xa. Biochemistry 2002; 41: 6780-6788.
19. Yang L, Manithody C, Olson ST, Rezaie AR. Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa. J Biol Chem 2003; 278: 25032-25038.
20. Yang L, Manithody C, Razaie AR. The functional significance of the autolysis loop in protein C and activated protein C. Thromb Haemost 2005; 94: 60-68.
21. Rezaie AR, Esmon CT. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J Biol Chem 1992; 267: 26104-26109.
22. Yang L, Manithody C, Rezaie AR. Contribution of basic residues of the 70-80-loop to haparin binding and anticoagulant function of activated protein C. Biochemistry 2002; 41: 6149-6157.
23. Smirnov MD, Esmon CT. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 1994; 269: 816-819.
24. Chen L, Manithody C, Yang L, Rezaie AR. Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa. Protein Sci 2004; 13: 431-442.
25. Gruber A, Griffin JH. Direct detection of activated protein C in blood from human subjects. Blood 1992; 79: 2340-2348.
26. Johnson DJ, Li W, Adams TE, Huntington JA. Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J 2006; 25: 2029-2037.
27. Mather T, Oganessyan V, Hof P, Huber R, Foundling S, Esmon C, et al. The 2.8 Å crystal structure of Gla-domainless activated protein C. EMBO J 1996; 15: 6822-6831.
28. Adler M, Davey DD, Phillips GB, Kim SH, Jancarik J, Rumennik G, et al. Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (C1-1031) complexed with factor Xa. Biochemistry 2000; 39: 12534-12542.
29. Gale AJ, Heeb MJ, Griffin JH. The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites. Blood 2000; 96: 585-593.